期刊文献+

心肌细胞凋亡信号传导通路与心肌损伤 被引量:6

Myocytes apoptosis signal transduction pathways and the myocardium injury
下载PDF
导出
摘要 在心肌损伤中,心肌细胞凋亡信号通路包括了依赖于caspase的信号途径和不依赖于caspase的信号途径,以及炎性反应、氧化及自噬等信号机制的交联和激活信号途径,心肌细胞的凋亡信号通路决定着心肌的生存与死亡,对心肌损伤的发生、发展及预后产生重要影响。 The cardiac myocyte apoptosis signal transduction includes caspase-dependend pathways and caspase-independend pathway,and also involve crosstalk or interaction with the inflammation,oxidation stress,autophagy and other mechanisms signal networks in myocardium injury.The apoptotic signaling pathway control the life cycle of cardiac myocyte in the heart.It has a great impact on the development and prognosis of the myocardium injury.
作者 戴日新 李浪
出处 《基础医学与临床》 CSCD 北大核心 2010年第7期775-777,共3页 Basic and Clinical Medicine
基金 国家自然科学基金(C030313)
关键词 信号传导 凋亡 心肌细胞 心肌损伤 signal transduction apoptosis myocytes myocardium injury
  • 相关文献

参考文献17

  • 1Garg S, Narula JA, Chandrashekhar Y. Apoptosis and heart failure: clinical relevance and therapeutic target [J]. J Mol Cell Cardiol, 2005, 38(1):73 -79. 被引量:1
  • 2Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease [J]. Apoptosis, 2009, 14(4) :536 -548. 被引量:1
  • 3Diwan A, Krenz M, Syed FM, et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice [ J ]. J Clin Invest, 2007, 117(10) :2825 -2833. 被引量:1
  • 4Hughes PD, Belz GT, Fortner KA, et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity [J]. Immunity, 2008, 28(2) :197 -205. 被引量:1
  • 5Youle R J, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death[ J]. Nat Rev Mol Cell Biol, 2008, 9(1):47-59. 被引量:1
  • 6Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? [ J ]. Trends Cell Biol, 2008, 18(4) :157 - 164. 被引量:1
  • 7Blum A. Heart failure-new insights [J]. Isr Med Assoc J, 2009, 11(2) :105 -111. 被引量:1
  • 8Hamid T, Gu Y, Ortines RV, et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure : role of nuclear factor-kappaB and inflammatory activation [J]. Circulation, 2009, 119(10):1386- 1397. 被引量:1
  • 9Abbate A, Salloum FN, Vecile E, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction [J]. Circulation, 2008, 117(20) :2670 -2683. 被引量:1
  • 10Bhuiyan MS, Takada Y, Shioda N, et al. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein [J]. Cardiovasc Ther, 2008, 26(1):10-23. 被引量:1

同被引文献83

  • 1Arias R, Sung M, Vasylyev D, et al. Amiloride is neuroprotective in an MPTP model of Parkinson's disease [ J ]. Neurobiol Dis, 2008, 31:334-341. 被引量:1
  • 2Marl Y, Katnik C, Cuevas J. ASICla channels are activated by endogenous protons during ischemia and contribute to synergistic potentiation of intracellular Ca (2+) overload during ischemia and acidosis [ J ]. Cell calcium, 2010, 48: 70 - 82. 被引量:1
  • 3Rabinowitz J, White E. Autophagy and metabolism [ J ]. Science, 2010, 330: 1344- 1348. 被引量:1
  • 4Alvarez-Erviti L, Rodriguez-Oroz M, Cooper J, et al. Chaperone-mediated autophagy markers in Parkinson disease brains[J]. Arch Neurol, 2010, 67: 1464- 1472. 被引量:1
  • 5Wong H, Bauer P, Kurosawa M, et al. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism [J]. Hum Mol Genet, 2008, 17:3223 -3235. 被引量:1
  • 6Xilouri M, Stefanis L. Autophagy in the central nervous system: implications for neurodegenerative disorders [ J ]. CNS Neurol Disord Drug Targets, 2010, 9:701 -719. 被引量:1
  • 7Wang Y, Singh R, Xiang Y, et al. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress [ J]. Hepatology, 2010, 52: 266 - 277. 被引量:1
  • 8Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono) : a randomised, 52-week, phase III, double-blind, parallel-treatment trial[ J]. Lancet, 2009, 373:473 -481. 被引量:1
  • 9Zinman B, Gerich J, Buse JB, et al. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in pa- tients with type 2 diabetes (LEAD-4 Met + TZD)[ J]. Dia- betes Care, 2009, 32: 1224- 1230. 被引量:1
  • 10Halbirk M, Norrelund H, Moiler N, et al. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infu- sion in compensated chronic patients with heart failure[ J ]. Am J Physiol Heart Circ Physiol, 2010,298 :H1096- H1102. 被引量:1

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部